Enzyme-encapsulated silica nanoparticle for cancer chemotherapy

Journal of Nanoparticle Research

Volumn 14, Issue 4, 2012, Pages

  Chiu, Yi Rong ^a   Ho, Wei Jen ^a   Chao, Jiun Shuan ^a   Yuan, Chiun Jye ^a  

^a NATIONAL CHIAO TUNG UNIVERSITY   (Taiwan)

Author keywords

Enzyme encapsulation; HRP; IAA; Nanomedicine; Prodrug cancer therapy; Silicate nanoparticle

Indexed keywords

CHEMOTHERAPY; DISEASES; ENZYMES; FOOD PRODUCTS; HIGH RESOLUTION TRANSMISSION ELECTRON MICROSCOPY; MEDICAL NANOTECHNOLOGY; NANOPARTICLES; ONCOLOGY; SCANNING ELECTRON MICROSCOPY; SILICA; SILICATES;

BIOLOGICAL PROPERTIES; ENZYME ENCAPSULATION; HORSE-RADISH PEROXIDASE; OPERATIONAL STABILITY; PH-DEPENDENT ACTIVITY; PRODRUG CANCER THERAPIES; RELATIVE STANDARD DEVIATIONS; SILICATE NANOPARTICLES;

SILICA NANOPARTICLES;

HORSERADISH PEROXIDASE; INDOLEACETIC ACID; NANOPARTICLE; SILICON DIOXIDE;

ARTICLE; CANCER CELL; CANCER CHEMOTHERAPY; CELL DEATH; CELL VIABILITY; DRUG STABILITY; FEASIBILITY STUDY; NANOENCAPSULATION; PARTICLE SIZE; PH; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY;

EID: 84858958654     PISSN: 13880764     EISSN: 1572896X     Source Type: Journal    
DOI: 10.1007/s11051-012-0829-1     Document Type: Article

References (46)

1. Ahmad S, Tester RF, Corbett A, Karkalas J (2006) Dextran and 5-aminosalicylic acid (5-ASA) conjugates: synthesis, characterisation and enzymic hydrolysis. Carbohydr Res 341:2694-2701 (Pubitemid 44572199)
2. Alexis F, Rhee JW, Richie JP, Radovic-Moreno AF, Langer R, Farokhzad OC (2008) New frontiers in nanotechnology for cancer treatment. Urol Oncol: Semin Ori Invest 26:74-85
3. Amine A, Mohammadi H, Bourais I, Palleschi G (2006) Enzyme inhibition-based biosensors for food safety and environmental monitoring. Biosens Bioelectron 21:1405-1423 (Pubitemid 43122005)
4. Bae KH, Chung HJ, Park TG (2011) Nanomaterials for cancer therapy and imaging. Mol Cell 31:295-302
5. Bagshawe K (1990) Antibody-directed enzyme/prodrug therapy (ADEPT). Biochem Soc Trans 18:750-752 (Pubitemid 20359291)
6. Baroli B, Ennas MG, Loffredo F, Isola M, Pinna R, López-Quintela MA (2007) Penetration of metallic nanoparticles in human full-thickness skin.JInvest Dermatol 127:1701-1712 (Pubitemid 46933398)
7. Bauduin P, Nohmie F, Touraud D, Neueder R, Kunz W, Ninham BW (2006) Hofmeister specific-ion effects on enzyme activity and buffer pH: horseradish peroxidase in citrate buffer. J Mol Liq 123:14-19 (Pubitemid 41562816)
8. Candeias LP, Folkes LK, Porssa M, Parrick J, Wardman P (1996) Rates of reaction of indoleacetic acids with horseradish peroxidase compound I and their dependence on the redox potentials. Biochemistry 35:102-108 (Pubitemid 26036412)
9. Connors TA (1995) The choice of prodrugs for gene directed enzyme prodrug therapy of cancer. Gene Ther 2:702-709 (Pubitemid 26046568)
10. Connors TA, Knox RJ (1995) Prodrugs in cancer chemotherapy. Stem Cells 13:501-511
11. Farokhzad OC, Langer R (2006) Nanomedicine: developing smarter therapeutic and diagnostic modalities. Adv Drug Deliv Rev 58:1456-1459 (Pubitemid 44820502)
12. Ferrari M (2005) Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer 5:161-171 (Pubitemid 40314948)
13. Fuchs S, Kapp T, Otto H, Schoneberg T, Franke P, Gust R, Schlüter AD (2004) A set of surface-modified dendrimers with potential application as drug delivery vehicles: synthesis, in vitro cytotoxicity, and intracellular localization. Chemistry 10:1167-1192
14. Gallati H (1979) Horseradish peroxidase: a study of the kinetics and the determination of optimal reaction conditions, using hydrogen peroxide and 2, 2-azinobis 3-ethylbenzthiazo-line-6-sulfonic acid (ABTS) as substrates. J Clin Chem Clin Biochem 17:1-7 (Pubitemid 9081123)
15. Gazarian IG, Lagrimini LM, Mellon FA, Naldrett MJ, Ashby GA, Thorneley RN (1998) Identification of skatolyl hydroperoxide and its role in the peroxidase-catalysed oxidation of indol-3-yl acetic acid. Biochem J 333:223-232 (Pubitemid 28342513)
16. Gesson JP, Jacquesy JC, Mondon M, Petit P, Renoux B, An-drianomenjanahary S, Van Dufat-Trinh H, Koch M et al (1994) Prodrugs of anthracyclines for chemotherapy via enzyme-monoclonal antibody conjugates. Anticancer Drug Des 9:409-423 (Pubitemid 24343635)
17. Gopin A, Ebner S, Attali B, Shabat D (2006) Enzymatic activation of second-generation dendritic prodrugs: conjugation of self-immolative dendrimers with poly (ethylene glycol) via click chemistry. Bioconj Chem 17:1432-1440 (Pubitemid 44851487)
18. Guthaus E, Burgle M, Schmiedeberg N, Hocke S, Eickler A, Kramer MD, Sweep CG, Magdolen V et al (2002) uPA-silica-particles (SP-uPA): a novel analytical system to investigate uPA-uPAR interaction and to test synthetic uPAR antagonists as potential cancer therapeutics. Biol Chem 383:207-216 (Pubitemid 34224043)
19. Han HK, Amidon GL (2000) Targeted prodrug design to optimize drug delivery. AAPS PharmSci 2:E6
20. Hari Krishna D, Rao AR, Krishna DR (2003) Selective activation of anthracycline prodrugs for use in conjunction with ADEPT. Drug News Perspect 16:309-318 (Pubitemid 37176219)
21. Hiner ANP, Hernández-Ruíz J, Amao MB, García- Cánovas F, Acosta M (1996) A comparative study of the purity, enzyme activity, and inactivation by hydrogen peroxide of commercially available horseradish peroxidase isoen-zymes A and C. Biotechnol Bioeng 50:655-662 (Pubitemid 26152238)
22. Hinman RL, Lang J (1965) Peroxidase-catalyzed oxidation of indole-3-acetic acid. Biochemistry 4:144-158
23. 2-poly (dimethylsiloxane) hybrid material in the fabrication of amperometric biosensor. Anal Chim Acta 572:248-252
24. Hock SC, Ying YM, Wah CL (2011) A review of the current scientific and regulatory status of nanomedicines and the challenges ahead. PDA J Pharm Sci Technol 65:177-195
25. Huysmans G, Ranquin A, Wyns L, Steyaert J, Van Gelder P (2005) Encapsulation of therapeutic nucleoside hydrolase in functionalised nanocapsules.JControl Release 102:171-179 (Pubitemid 40093783)
26. Karlsson KH (1999) Bone implants-a challenge to materials science. Ann Chir Gynaecol 88:226-235 (Pubitemid 29472819)
27. Kawanabe K, Yamamuro T, Nakamura T, Kotani S (1991) Effects of injecting massive amounts of bioactive ceramics in mice. J Biomed Mater Res 25:117-1128
28. Kim DS, Jeon SE, Park KC (2004) Oxidation of indole-3-acetic acid by horseradish peroxidase induces apoptosis in G361 human melanoma cells. Cell Signal 16:81-88
29. Kobayashi S, Sugioka K, Nakano H, Nakano M, Tero-Kubota S (1984) Analysis of the stable end products and intermediates of oxidative decarboxylation of indole-3-acetic acid by horseradish peroxidase. Biochemistry 23:4589-4597
30. Kratz F, Warnecke A, Schmid B, Chung DE, Gitzel M (2006) Prodrugs of anthracyclines in cancer chemotherapy. Curr Med Chem 13:477-523
31. Li X, Zhang Y, Yan R, Jia W, Yuan M, Deng X, Huang Z (2000) Influence of process parameters on the protein stability encapsulated in poly-DL-lactide-poly (ethylene glycol) microspheres. J Control Release 68:41-52 (Pubitemid 30407060)
32. Matsoukas T, Gulari E (1988) Dynamics of growth of silica particles from ammonia-catalyzed hydrolysis of tetra-ethyl-orthosilicate. J Colloid Interface Sci 124:252-261 (Pubitemid 18660164)
33. Mauger AB, Burke PJ, Somani HH, Friedlos F, Knox RJ (1994) Self-immolative prodrugs: candidates for antibody-directed enzyme prodrug therapy in conjunction with a nitro-reductase enzyme. J Med Chem 37:3452-3458 (Pubitemid 24334600)
34. Nishi Y (2003) Enzyme/abzyme prodrug activation systems: potential use in clinical oncology. Curr Pharm Des 9: 2113-2130 (Pubitemid 37139088)
35. Park SK, Kim KD, Kim HT (2002) Preparation of silica nano-particles: determination of the optimal synthesis conditions for small and uniform particles. Colloids Surf A Physico-chem Eng Aspects 197:7-17 (Pubitemid 34017362)
36. Petri-Fink A, Chastellain M, Juillerat-Jeanneret L, Ferrari A, Hofmann H (2005) Development of functionalized super-paramagnetic iron oxide nanoparticles for interaction with human cancer cells. Biomaterials 26:2685-2694 (Pubitemid 39600721)
37. Qhobosheane M, Santra S, Zhang P, Tan W (2001) Biochemically functionalized silica nanoparticles. Analyst 126: 1274-1278 (Pubitemid 32747743)
38. Rodriguez-López JN, Gilabert MA, Tudela J, Thorneley RN, Garcia-Cánovas F (2000) Reactivity of horseradish per-oxidase compound II toward substrates: kinetic evidence for a two-step mechanism. Biochemistry 39:13201-13209
39. Rudolphi A, Vielhauer S, Boos KS, Seidel D, Bathge IM, Berger H (1995) Coupled-column liquid chromatographic analysis of epirubicin and metabolites in biological material and its application to optimization of liver cancer therapy. J Pharm Biomed Anal 13:615-623
40. Shchipunov YA, Karpenko TY, Bakunina IY, Burtseva YV, Zvyagintseva TN (2004) A new precursor for the immobilization of enzymes inside sol-gel-derived hybrid silica nanocomposites containing polysaccharides. J Biochem Biophys Methods 58:25-38 (Pubitemid 37352728)
41. Smith AM, Morrison WL, Milham PJ (1982) Oxidation of indole-3-acetic acid by peroxidase: involvement of reduced peroxidase and compound III with superoxide as a product. Biochemistry 21:4414-4419
42. Syrigos KN, Epenetos AA (1999) Antibody directed enzyme prodrug therapy (ADEPT): a review of the experimental and clinical considerations. Anticancer Res 19:605-613 (Pubitemid 29168301)
43. Van Helden AK, Jansen JW, Vrij A (1981) Preparation and characterization of spherical monodisperse silica dispersions in nonaqueous solvents. J Colloid Interface Sci 81: 354-368
44. Wardman P (2002) Indole-3-acetic acids and horseradish per-oxidase: a new prodrug/enzyme combination for targeted cancer therapy. Curr Pharm Res 8:1363-1374 (Pubitemid 34591352)
45. Wu X, Narsimha G (2008) Characterization of secondary and tertiary conformational changes of beta-lactoglobulin adsorbed on silica nanoparticle surfaces. Langmuir 24: 4989-4998 (Pubitemid 351725189)
46. Wu S, Lin J, Chan SI (1994) Oxidation of dibenzothiophene catalyzed by heme-containing enzymes encapsulated in sol-gel glass. A new form of biocatalysts. Appl Biochem Biotechnol 47:11-20